[从栓剂中获取丙苯氮唑啉。1. 体外生物利用度]
[Availability of propylphenazocine from suppositories. 1. In vitro bioavailability].
作者信息
Bornschein M, Voigt R, Hoffmann K
出版信息
Pharmazie. 1985 Oct;40(10):718-9.
PMID:4080788
Abstract
Comparing examinations of the in-vitro availability of propyphenazone from suppositories of different fat bases (Rosupol U, Witepsol H 15) did not display any differences in the release behaviour. Compared with propyphenazone preparations, aminophenazone suppositories of the same concentration exhibit a significantly increased in-vitro availability.
摘要
比较不同脂肪基质（Rosupol U、Witepsol H 15）的保泰松栓剂的体外释放情况，未发现释放行为有任何差异。与保泰松制剂相比，相同浓度的氨基苯丙酮栓剂的体外释放度显著增加。
相似文献
1
[Availability of propylphenazocine from suppositories. 1. In vitro bioavailability].[从栓剂中获取丙苯氮唑啉。1. 体外生物利用度]
Pharmazie. 1985 Oct;40(10):718-9.
2
[Availability of propylphenazone from suppositories. 2. Bioavailability].[栓剂中安替比林的可得性。2. 生物利用度]
Pharmazie. 1986 Apr;41(4):244-7.
3
Release of pyrazolone derivatives from suppositories formulated with hydrophilic and hydrophobic bases.
Pharmazie. 1986 May;41(5):338-40.
4
Effect of surfactant incorporation techniques on sulphamethoxazole suppository formulations.
Pharmazie. 1988 Sep;43(9):624-7.
5
[The bioavailability of trapidil from suppositories (author's transl)].曲匹地尔栓剂的生物利用度（作者译）
Pharmazie. 1981 Dec;36(12):830-2.
6
Biopharmaceutical studies of oral formulations containing propyphenazone.含保泰松的口服制剂的生物制药研究。
Pharmazie. 1987 Mar;42(3):184-6.
7
8
[The influence of method/apparatus conditions on the in vitro liberation of drugs from suppositories].[方法/仪器条件对栓剂药物体外释放的影响]
Pharmazie. 1986 Dec;41(12):852-4.
9
Zotero 插件